登录 注册 会员服务 联系我们

miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene

  • Published:2022-04 Issue: Volume:125 Page:104753
  • ISSN:0014-4800
  • Container-title:Experimental and Molecular Pathology
  • language:en
  • Short-container-title:Experimental and Molecular Pathology

Author:

Safaei Sahar,Amini Mohammad,Najjary Shiva,Mokhtarzadeh Ahad,Bolandi Nadia,Saeedi Hossein,Alizadeh Nazila,Javadrashid Darya,Baradaran Behzad

Funder

Ministry of Health and Medical Education

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference33 articles.

1. Circulating miR-200c and miR-141 and outcomes in patients with breast cancer;Antolín;BMC Cancer,2015

2. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non–small cell lung cancer;Ceppi;Mol. Cancer Res.,2010

3. Downregulation of miR-200c-3p contributes to the resistance of breast cancer cells to paclitaxel by targeting SOX2;Chen;Oncol. Rep.,2018

4. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1;Damiano;Genes Chromosom. Cancer,2017

5. Breast cancer statistics, 2019;DeSantis;CA Cancer J. Clin.,2019
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3